Chemclin Diagnostics Co., Ltd. (hereinafter it was referred to as Chemclin Diagnostics), founded in 2007, is one of the pioneers in developing clinical immunoassays and systems in China. Chemclin Diagnostics is specialized in the research and development, production, sales and service of In Vitro Diagnostics (IVD) products.
Currently, chemiluminescence immunology is the core business of Chemclin Diagnostics. In terms of technology, from the product development of radioimmunoassay and enzymatic chemiluminescence immunoassay to the cross-generation technology platform of Light-initiated Chemiluminescence Immunoassay (LiCA), Chemclin’s R&D team has accumulated rich experiences in the product development on assays and automated systems. Among them, LiCA is a leading immunoassay technology platform in both China and overseas. LiCA is a unique technology with the integration of varies of cutting edge technologies, such as, nanoparticle polymers, light-initiated chemiluminescent signaling technology, wash-free immunoassay technology and the corresponding automation technologies. At present, Chemclin Diagnostics has successfully developed assays for multiple disease panels and series of automated LiCA systems.